Exciting updates from Session II at ACCELERATE cure 2024 Annual Conference – ACCELERATE Multi-Stakeholder Platform

ACCELERATE Multi-Stakeholder Platform shared on LinkedIn:

“Exciting updates from Session II at ACCELERATE cure 2024 Annual Conference!

Today kicked off with insightful presentations from European Medicines Agency and FDA, shedding light on regulatory developments in the EU and USA. Later, we delved into updates on ACCELERATE initiatives including Logbook, FAIR Working Group, ALADDIN Education and the brand-new Patient-Reported Outcomes Working Group. Plus, highlights from the advocate workshop ‘The scientific and moral dilemma of randomizing hope in children’s cancers with poor prognosis’. Stay tuned for more information!

As we wrap up day one, we extend a heartfelt thank you to all participants for their active contributions and stimulating discussions. Looking forward to another enriching day tomorrow, focusing on international academic trials for pediatric drug development and enhancing academia’s access to investigational drugs.”

Source: ACCELERATE Multi-Stakeholder Platform/LinkedIn